Catastrophic Concomitant Arterial and Venous Thrombosis in a Mild COVID-19-Positive Patient.
Raka Aldy NugrahaHary S MuliawanNyityasmono Tri NugrohoMuhammad IkhsanSuko AdiartoPublished in: The International journal of angiology : official publication of the International College of Angiology, Inc (2021)
Since its first discovery in late 2019, coronavirus disease 2019 (COVID-19) has been a global burden associated with significant morbidity and mortality. COVID-19 has been correlated with the development of hypercoagulable state that predisposes the patients to a higher risk of thromboembolism. Current evidence suggests higher incidence of thrombosis, particularly venous thrombosis, among hospitalized COVID-19 patients, mostly with critical illness. On the other hand, there is currently no data regarding the incidence of vivid thrombosis in ambulatory patients with mild COVID-19 and the incidence of concomitant arterial and venous thrombosis in COVID-19 is extremely rare. Herein, we describe catastrophic outcomes of concomitant lower limb arterial and venous thrombosis in a patient with mild COVID-19. This report highlights the occurrence of concomitant arterial and venous thrombosis in ambulatory setting and that this phenomenon resulted in catastrophic clinical consequences.
Keyphrases
- coronavirus disease
- sars cov
- respiratory syndrome coronavirus
- risk factors
- blood pressure
- lower limb
- pulmonary embolism
- end stage renal disease
- type diabetes
- case report
- newly diagnosed
- machine learning
- electronic health record
- insulin resistance
- skeletal muscle
- weight loss
- adipose tissue
- high throughput
- glycemic control